Breast Cancer Clinical Trial
Official title:
Ambulatory Cancer Pain Management: A Feasibility Study
The primary purpose of this study is to examine the feasibility of collecting pain and other
symptom data in outpatient treatment centers across multiple institutions in the Texas
Medical Center (TMC). We will also examine the prevalence and severity of cancer-related
pain and begin to identify other commonly reported symptoms in outpatient settings. Factors
that interfere with management of pain will also be examined. Additionally, the study will
explore patient satisfaction with pain management and pain education in outpatient settings.
The specific aims of this study include:
Primary Objective:
-Explore the feasibility of a collaborative effort by oncology nurses to collect pain and
symptom data across multiple institutions that care for ambulatory cancer patients in the
TMC.
Secondary Objectives:
- Describe the prevalence and severity of pain and other symptoms in persons with breast,
colorectal, lung, or prostate cancer who are receiving chemotherapy in the outpatient
setting.
- Describe factors that interfere with adequate pain management in these patients.
- Examine patient satisfaction with pain management and patient education about pain
management.
You will be asked to complete 3 questionnaires that will take a total of about 20 minutes to
complete. Your name or medical record number will not appear on the questionnaires. You will
be assigned a study subject code number. The study chair will keep a file that links your
name to the code.
The first questionnaire will ask for basic demographic information (such as gender,
ethnicity, and education) and your current chemotherapy and pain medications. If you cannot
remember the names of these medications, researchers will locate them in your M. D. Anderson
medical record.
The second questionnaire asks you to rate your pain and a variety of symptoms (for example,
fatigue and nausea).
The last questionnaire includes 3 sections. The first section asks about your beliefs about
pain and its treatment. The second part asks for your opinion about your pain management and
about the education you have received about pain management. On the last page, you will be
asked to use a picture of the outline of a body to show the researchers where you have pain.
Once you have completed these questionnaires, you will be considered off-study.
This is an investigational study. Up to 125 patients will take part in this study. Up to 35
will be enrolled at M. D. Anderson.
;
Observational Model: Case-Only, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A |